Kathleen Sebelius Humacyte, Inc. (HUMA) insider trading activity

Kathleen Sebelius is Director of Humacyte, Inc.. Currently has a direct ownership of 91,207 shares of HUMA, which is worth approximately $220,720. The most recent transaction as insider was on Apr 08, 2025, when has been sold 50,000 shares (Common Stock) at a price of $1.32 per share, resulting in proceeds of $66,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 91.2K

0% 3M change

131.55% 12M change

Total Value Held $220,720

Kathleen Sebelius Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 08 2025	BUY Open market or private purchase	$66,000 $1.32 p/Share	50,000 Added 35.41%	91,207 Common Stock
Sep 10 2024	SELL Open market or private sale	$27,982 $5.4 p/Share	5,182 Reduced 11.17%	41,207 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	$26,950 $3.85 p/Share	7,000 Added 14.07%	42,755 Common Stock
Jun 14 2024	BUY Exercise of conversion of derivative security	$100,835 $2.56 p/Share	39,389 Added 50.0%	39,389 Common Stock

Also insider at

EXAS

EXACT SCIENCES CORP Healthcare